183 related articles for article (PubMed ID: 11881119)
1. Pre-treatment with candesartan protects from cerebral ischaemia.
Ito T; Nishimura Y; Saavedra J
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):174-9. PubMed ID: 11881119
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats.
Nishimura Y; Ito T; Saavedra JM
Stroke; 2000 Oct; 31(10):2478-86. PubMed ID: 11022082
[TBL] [Abstract][Full Text] [Related]
3. Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition.
Yamakawa H; Jezova M; Ando H; Saavedra JM
J Cereb Blood Flow Metab; 2003 Mar; 23(3):371-80. PubMed ID: 12621312
[TBL] [Abstract][Full Text] [Related]
4. Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist.
Ito T; Yamakawa H; Bregonzio C; Terrón JA; Falcón-Neri A; Saavedra JM
Stroke; 2002 Sep; 33(9):2297-303. PubMed ID: 12215602
[TBL] [Abstract][Full Text] [Related]
5. Postischemic administration of angiotensin II type 1 receptor blocker reduces cerebral infarction size in hypertensive rats.
Omura-Matsuoka E; Yagita Y; Sasaki T; Terasaki Y; Oyama N; Sugiyama Y; Okazaki S; Sakoda S; Kitagawa K
Hypertens Res; 2009 Jul; 32(7):548-53. PubMed ID: 19424281
[TBL] [Abstract][Full Text] [Related]
6. Effects of candesartan on angiotensin II-induced renal vasoconstriction in rats and mice.
Ruan X; Purdy KE; Oliverio MI; Coffman TM; Arendshorst WJ
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S202-7. PubMed ID: 9892164
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation.
Vraamark T; Waldemar G; Strandgaard S; Paulson OB
J Hypertens; 1995 Jul; 13(7):755-61. PubMed ID: 7594439
[TBL] [Abstract][Full Text] [Related]
8. The angiotensin AT1 receptor antagonist CV-11974 regulates cerebral blood flow and brain angiotensin AT1 receptor expression.
Nishimura Y; Xu T; Jöhren O; Häuser W; Saavedra JM
Basic Res Cardiol; 1998; 93 Suppl 2():63-8. PubMed ID: 9833166
[TBL] [Abstract][Full Text] [Related]
9. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
[TBL] [Abstract][Full Text] [Related]
10. Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats.
Bennai F; Morsing P; Paliege A; Ketteler M; Mayer B; Tapp R; Bachmann S
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S104-15. PubMed ID: 9892150
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment with ibuprofen and the AT1 receptor antagonist candesartan in young spontaneously hypertensive rats.
Pollock DM; Morsing P
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S116-9. PubMed ID: 9892151
[TBL] [Abstract][Full Text] [Related]
12. Candesartan normalizes exaggerated tubuloglomerular feedback activity in young spontaneously hypertensive rats.
Brännström K; Morsing P; Arendshorst WJ
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S213-9. PubMed ID: 9892166
[TBL] [Abstract][Full Text] [Related]
13. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke.
Brdon J; Kaiser S; Hagemann F; Zhao Y; Culman J; Gohlke P
J Hypertens; 2007 Jan; 25(1):187-96. PubMed ID: 17143191
[TBL] [Abstract][Full Text] [Related]
14. Chronic AT1-receptor blockade does not alter cerebral oxygen supply/demand ratio during cardiopulmonary bypass in hypertensive patients.
Kottenberg-Assenmacher E; Massoudy P; Jakob H; Philipp T; Peters J
Acta Anaesthesiol Scand; 2008 Jan; 52(1):73-80. PubMed ID: 17976222
[TBL] [Abstract][Full Text] [Related]
15. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
Kim S; Iwao H
J Hypertens Suppl; 1997 Dec; 15(6):S3-7. PubMed ID: 9493120
[TBL] [Abstract][Full Text] [Related]
16. Candesartan cilexetil protects against loss of autoregulatory efficiency in angiotensin II-infused rats.
Inscho EW; Imig JD; Deichmann PC; Cook AK
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S178-83. PubMed ID: 9892160
[TBL] [Abstract][Full Text] [Related]
17. AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats.
Zhou J; Pavel J; Macova M; Yu ZX; Imboden H; Ge L; Nishioku T; Dou J; Delgiacco E; Saavedra JM
Stroke; 2006 May; 37(5):1271-6. PubMed ID: 16601219
[TBL] [Abstract][Full Text] [Related]
18. Candesartan cilexetil protects cavernous tissue in spontaneously hypertensive rats.
Toblli JE; Stella I; Mazza ON; Ferder L; Inserra F
Int J Impot Res; 2004 Aug; 16(4):305-12. PubMed ID: 15103316
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II AT1 receptor blockade decreases brain artery inflammation in a stress-prone rat strain.
Ando H; Jezova M; Zhou J; Saavedra JM
Ann N Y Acad Sci; 2004 Jun; 1018():345-50. PubMed ID: 15240389
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats.
Ando H; Zhou J; Macova M; Imboden H; Saavedra JM
Stroke; 2004 Jul; 35(7):1726-31. PubMed ID: 15143297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
